Earnings Ahead

LLY - Eli Lilly & Co

726.31 -19.64 -2.63

Eli Lilly & Co

Eli Lilly & Co

About

Profile

Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was thi


Headquarters

Indianapolis, Indiana, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

LLY

Eli Lilly on Wednesday said its partnering with Amazon Pharmacy to help deliver certain prescription drugs, including weight loss treatment Zepbound. Shares of Eli Lilly gained nearly 1%, while Amazon shares were slightly lower.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Lilly reportedly worried about impact of Catalent/Novo deal
  • Eli Lilly hurts NASH drug developers after mid-stage win for obesity therapy
  • Biggest stock movers today: DocuSign, BP, Palantir Technologies, and more
  • 6 stocks to watch on Tuesday: Spotify, Eli Lilly, Chipotle, DocuSign and more
  • Eli Lilly in charts: Verzenio and Mounjaro drive revenue growth, while Humalog and Trulicity decline
  • Eli Lilly beats in Q4 as obesity drug sales blow past estimates
  • Eli Lilly beats top-line and bottom-line estimates; initiates FY24 outlook
  • Eli Lilly Q4 results to highlight Zepbound uptake
  • Eli Lilly sees highest intraday trade since November ahead of earnings
  • Progressive and Universal Health are added into BofA’s Growth screen for February
  • Amgen weight loss drug shows promising early data
  • Catalyst watch: Alibaba earnings, World Defense Show, Fed speakers unleashed and Super Bowl buzz
  • AbbVie cites tailwinds to Botox business from weight loss drugs
  • Lilly, Zoetis, Abbott least shorted stocks in S&P 500 health sector in mid-Jan
  • U.S. govt. opens bids in Medicare drug price negotiations
  • NeuroBo to begin Phase 1 testing of potential Wegovy rival
  • Lilly, Novo could be first trillion-dollar health stocks: world's largest sovereign wealth fund
  • Eli Lilly wins Canada approval for severe hair loss therapy
  • Karuna’s KarXT tops Evaluate’s most anticipated drug list
  • Eli Lilly said to be in talks with Germany to win coverage for weight loss drugs

Earnings History

Date EPS / Forecast Revenue / Forecast
February 3, 2022 2.49 / 2.45 8B / 7.69B Beat!
October 26, 2021 1.94 / 1.96 6.77B / 6.64B Beat!
August 3, 2021 1.87 / 1.89 6.74B / 6.6B Beat!
April 27, 2021 1.87 / 2.12 6.81B / 6.93B
January 29, 2021 2.75 / 2.37 7.44B / 7.27B Beat!
October 27, 2020 1.54 / 1.71 5.74B / 5.88B
July 30, 2020 1.89 / 1.56 5.5B / 5.76B
April 23, 2020 1.75 / 1.48 5.86B / 5.49B Beat!
January 30, 2020 1.73 / 1.52 6.11B / 5.91B Beat!
October 23, 2019 1.48 / 1.4 5.48B / 5.5B
July 30, 2019 1.5 / 1.45 5.64B / 5.58B Beat!
April 30, 2019 1.33 / 1.31 5.09B / 5.2B
February 6, 2019 1.33 / 1.34 6.44B / 6.29B Beat!
November 6, 2018 1.39 / 1.35 6.06B / 6.03B Beat!
July 24, 2018 1.5 / 1.3 6.36B / 6.05B Beat!
April 24, 2018 1.34 / 1.13 5.7B / 5.52B Beat!
January 31, 2018 1.14 / 1.07 6.16B / 5,934M Beat!
October 24, 2017 1.05 / 1.03 5.66B / 5.52B Beat!
July 25, 2017 1.11 / 1.05 5.82B / 5.60B Beat!
April 25, 2017 0.98 / 0.96 5.23B / - Beat!
Date Price Open High Low Vol Change
Apr 18 745.92 749.82
752.16
743.79
1.3M -0.6%
Apr 17 750.45 759.2
770.85
744.88
2.8M 0.50%
Apr 16 746.71 751.9
753.14
743.15
2.0M -0.58%
Apr 15 751.03 759.72
768
749.52
1.8M 0%
Apr 12 751.05 759.5
763.15
749.78
1.9M -1.03%
 
Apr 11 758.86 759.62
763.33
750.85
1.3M -0.41%
Apr 10 761.98 750.76
765.26
748.04
1.6M 0.63%
Apr 9 757.24 776.26
776.28
750.7
2.4M -2.62%
Apr 8 777.6 784.5
785.2
773.35
1.4M -0.84%
Apr 5 784.21 766.12
786.71
763.28
2.1M 2.10%
Apr 4 768.08 780.68
787.9
767.82
2.3M -1.02%
Apr 3 775.99 766
787.23
765.49
2.9M 1.57%
Apr 2 763.96 754.83
765.07
753.85
2.6M 0.45%
Apr 1 760.55 775.35
776.02
754.02
2.9M -2.24%
Mar 28 777.96 780.69
793.59
777.91
3.2M -0.03%
Mar 27 778.18 780.99
785.25
767.61
2.3M 0.42%
Mar 26 774.9 773.46
778.33
769
2.1M 0.23%
Mar 25 773.14 771.65
778.28
768.2
1.8M 0.36%
Mar 22 770.34 772.46
777
767.28
1.6M 0.08%
Mar 21 769.74 771.61
780.54
759.09
2.6M -0.4%
Mar 20 772.86 770.11
773.16
756.64
2.0M 0.01%
Mar 19 772.78 758.44
773.85
755
2.5M 1.33%
Mar 18 762.66 762.28
769.68
758.25
2.5M 1.13%
Mar 15 754.17 755.38
760.89
747.71
3.7M -0.86%
Mar 14 760.73 764.95
768
749.4
2.6M 0.38%
Mar 13 757.84 757
760.77
745.71
2.4M 0.38%
Mar 12 754.95 740.96
755.97
738.01
2.7M 2.80%
Mar 11 734.37 752.21
756.8
727.62
4.0M -3.64%
Mar 8 762.14 780
780
755
4.1M -2.31%
Mar 7 780.16 771.84
792.99
761.12
3.9M 0.05%
Mar 6 779.77 784.29
787.85
774
2.5M 0.28%
Mar 5 777.59 785.31
788.53
769.28
3.1M -1.85%
Mar 4 792.28 796.44
800.78
786.16
3.8M 1.30%
Mar 1 782.12 769.02
784.08
764.13
4.2M 3.77%
Feb 29 753.68 753.08
756.46
744.03
3.9M -0.52%
Feb 28 757.64 762.25
763
751.66
2.7M -0.96%
Feb 27 765 754.9
772.95
745.44
2.7M -0.9%
Feb 26 771.92 771.3
780.22
769.12
2.2M 0.31%
Feb 23 769.54 774
777.65
762.26
2.4M -0.01%
Feb 22 769.64 763.58
775.12
756.27
3.1M 3.18%
Feb 21 745.91 738.08
749.5
733.24
3.5M -1.29%
Feb 20 755.66 790
793.38
753.2
4.7M -3.38%
Feb 16 782.06 771.03
794.47
763.5
5.0M 3.20%
Feb 15 757.78 755.8
762.99
750.01
2.4M 0.06%
Feb 14 757.31 745.82
764.05
745
3.3M 1.93%
Feb 13 742.97 730.18
742.98
730.18
2.8M 0.77%
Feb 12 737.26 740.8
740.8
726.45
2.9M -0.39%
Feb 9 740.16 735.5
745.7
733.61
2.8M 0.61%
Feb 8 735.68 728.32
741
725.75
4.5M 1.42%
Feb 7 725.38 710.38
740.99
707.02
5.8M 2.89%
Feb 6 705.03 742
742
691.1
8.2M -0.17%
Feb 5 706.2 691.02
711.88
682.53
7.3M 5.77%
Feb 2 667.65 662.38
672.61
659.73
3.0M 1.09%
Feb 1 660.43 647.33
660.52
643.17
2.5M 2.30%
Jan 31 645.61 650.38
663.55
637
4.7M 0.10%
Jan 30 644.98 645.7
646.8
641
1.9M 0%
Jan 29 645 641.5
645.65
639.77
2.7M 0.90%
Jan 26 639.25 637.35
639.6
630.5
2.4M 1.85%
Jan 25 627.62 627.37
632.61
624.68
2.4M -0.96%
Jan 24 633.7 633.52
643.16
632
2.2M 0%